Silencing of CSN5 gene expression using interfering RNA

Details for Australian Patent Application No. 2009236219 (hide)

Owner Provita Biotherapeutics, Inc. The United States of America as represented by The Secretary, Department of Health and Human Services

Inventors Thorgeirsson, Snorri S.; Judge, Adam; Maclachlan, Ian; Lee, Yun-Han

Agent Davies Collison Cave

Pub. Number AU-A-2009236219

PCT Pub. Number WO2009/129319

Priority 61/045,251 15.04.08 US

Filing date 15 April 2009

Wipo publication date 22 October 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/129319 Priority application(s): WO2009/129319

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009236220-Protein concentrate from starch containing grains: composition, method of making, and uses thereof

2009236216-Minimally invasive treatment of vertebra (MITV) using a calcium phosphate combination bone cement